Cargando…
Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.
The effect of combining photodynamic therapy (PDT) and bioreductive drugs has been investigated using the RIF-1 experimental murine tumour. Light was delivered interstially to the tumour at 675 nm using a single optical fibre attached to an argon-ion dye laser. The photosensitizer was disulphonated...
Autores principales: | Bremner, J. C., Adams, G. E., Pearson, J. K., Sansom, J. M., Stratford, I. J., Bedwell, J., Bown, S. G., MacRobert, A. J., Phillips, D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978041/ https://www.ncbi.nlm.nih.gov/pubmed/1457346 |
Ejemplares similares
-
The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
por: Keohane, A., et al.
Publicado: (1990) -
Distribution of pimonidazole and RSU 1069 in tumour and normal tissues.
por: Cobb, L. M., et al.
Publicado: (1990) -
Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
por: Adams, G. E., et al.
Publicado: (1984) -
Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
por: Hill, R. P., et al.
Publicado: (1986) -
The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
por: Stratford, I. J., et al.
Publicado: (1986)